Wang published in ACS Nano

August 18, 2015

UNC Lineberger member Andrew Wang, MD, was senior author of a preclinical study published in the journal ACS Nano. Wang and collaborators found that they could improve cancer chemotherapy and chemoradiotherapy treatments by delivering a combination of cancer-fighting drugs using nanoparticles.

Sleep for Cells

February 12, 2015

With new funding, a UNC startup is poised to halt the most devastating effects of chemotherapy.

UNC researchers pinpoint chemo effect on brain cells

December 3, 2014

UNC Lineberger members and UNC School of Medicine researchers have found for the first time a biochemical mechanism that could be a cause of “chemo brain” – the neurological side effects such as memory loss, confusion, difficulty thinking, and trouble concentrating that many cancer patients experience while on chemotherapy to treat tumors in other parts of the body.

UNC researchers show cancer chemotherapy accelerates ‘molecular aging’

March 28, 2014

Physicians have long suspected that chemotherapy can accelerate the aging process in patients treated for cancer. Using a test developed at UNC Lineberger Comprehensive Cancer Center to determine molecular aging, UNC oncologists have directly measured the impact of anti-cancer chemotherapy drugs on biological aging.

NIH grant to improve efficiency of chemotherapy drugs

February 6, 2014

A team led by Cyrus Vaziri, PhD, and William Janzen at the University of North Carolina at Chapel Hill has received a grant from the National Institutes of Health for research that could help make chemotherapy drugs more effective.